Clinical neuropsychiatry
February 1, 2024
Thales Marcon Almeida, Ursula Raianny Lacerda da Silva, Jeully Pereira Pires et al.
20 citations
Post-traumatic stress disorder (PTSD) is an enduring condition characterized by a chronic course and impairments across several areas. Despite its significance, treatment options remain limited, and remission rates are often low. Ketamine has demonstrated antidepressant properties and appears to be a promising agent in the management of PTSD. A systematic review was conducted in PubMed/MEDLINE,...
Clinical neuropsychiatry
October 1, 2023
Mario Miniati, Graziella Orrù, Mery Paroli et al.
7 citations
To investigate mindfulness traits/attitudes as protective factors against chronic pain related distress, depression and anxiety. Fifty patients (25 with chronic non-oncologic pain-NOP; 25 with chronic oncologic pain-COP) were administered with the following scales: Visual Analogue Scale (VAS), Pain Disability Index (PDI), Italian Questionnaire for Pain (QUID), Perceived Stress Scale (PSS),...
Clinical neuropsychiatry
June 1, 2022
Although psychosis is not one of the most commonly recognized psychiatric comorbidities of Eating Disorders (ED), there is an increasing empirical evidence of associations between these psychopathological conditions. Indeed, ED as well as early manifestations of schizophrenic psychosis emerge during developmental years and might present some affinities in the presentation at onset. For example,...
Clinical neuropsychiatry
June 1, 2021
Massimo Prior, Teresa Mercogliano, Giorgio Pigato et al.
The present work depicts the case of a young man suffering from a depersonalization and derealization (DD) disorder, which mainly affects his own body. When the symptoms concern something else, they almost exclusively affect living beings. Neuropsychological and neuropsychiatric studies, as well as functional neuroanatomy studies, have led to hypothesize possible relationships among...
Clinical neuropsychiatry
December 1, 2020
Federico J Gómez-Busto, Mario I Ortiz
12 citations
OBJECTIVE: Hallucinogenic substances or psychedelic drugs have been historically used by humans worldwide for centuries, and interest grows around them because of the therapeutic potential that they pose for mental disease. Virtual Reality (VR), has been highly developed and improved in the last decade, and it is also gaining importance due to their potential as therapeutic tools. In this...